507 related articles for article (PubMed ID: 9181277)
21. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
[TBL] [Abstract][Full Text] [Related]
22. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
[TBL] [Abstract][Full Text] [Related]
23. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
Nielsen CB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II natriuresis and anti-natriuresis: role of renal artery pressure in anaesthetized dogs.
Olsen ME; Hall JE; Montaini JP; Guyton AC
J Hypertens Suppl; 1984 Dec; 2(3):S347-50. PubMed ID: 6599679
[TBL] [Abstract][Full Text] [Related]
25. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
26. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
27. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
[TBL] [Abstract][Full Text] [Related]
28. Influence of captopril on renal hemodynamics and segmental tubular reabsorption of sodium in humans.
Hannedouche T; Delgado A; Gnionsahe A; Lacour B; Grunfeld JP
J Cardiovasc Pharmacol; 1989 Jan; 13(1):84-9. PubMed ID: 2468940
[TBL] [Abstract][Full Text] [Related]
29. Increased nocturnal sodium excretion in obstructive sleep apnoea. Relation to nocturnal change in diastolic blood pressure.
Gjørup PH; Sadauskiene L; Wessels J; Nyvad O; Strunge B; Pedersen EB
Scand J Clin Lab Invest; 2008; 68(1):11-21. PubMed ID: 18224555
[TBL] [Abstract][Full Text] [Related]
30. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
31. Effects of acute volume loading on kidney function in patients with essential hypertension, as estimated by the lithium clearance method.
Holstein-Rathlou NH; Svendsen UG; Leyssac PP
J Hypertens; 1985 Oct; 3(5):511-6. PubMed ID: 4067307
[TBL] [Abstract][Full Text] [Related]
32. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
33. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
Barendregt JN; Florijn KW; Muizert Y; Chang PC
Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
[TBL] [Abstract][Full Text] [Related]
34. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
[TBL] [Abstract][Full Text] [Related]
35. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
[TBL] [Abstract][Full Text] [Related]
36. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
37. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic factor after heart operations in children. Relation to hemodynamic and renal parameters.
Girardin EP; Berner ME; Favre HR; Oberhaensli I; Rouge JC; Friedli B; Paunier L
J Thorac Cardiovasc Surg; 1991 Oct; 102(4):526-31. PubMed ID: 1833593
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
40. Renal tubular responses to low-dose infusion of angiotensin II in type 1 diabetes mellitus; relation to chronic glycaemic control.
Eadington DW; Frier BM; Swainson CP
Nephrol Dial Transplant; 1994; 9(9):1264-70. PubMed ID: 7816287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
